Crinetics Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Crinetics Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $101.54 million for the year ending 2025.

  • Crinetics Pharmaceuticals, Inc. showed a decrease of -61.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Crinetics Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), Crinetics Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 615.4%.
  • Historical annual values: Fiscal year 2025: $101.54 million | Fiscal year 2024: $264.55 million | Fiscal year 2023: $54.90 million | Fiscal year 2022: $32.67 million | Fiscal year 2021: $200.70 million | Fiscal year 2020: $93.09 million | Fiscal year 2019: $40.33 million | Fiscal year 2018: $44.97 million | Fiscal year 2017: $14.19 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: